Search

Your search keyword '"Forster, Martin"' showing total 326 results

Search Constraints

Start Over You searched for: Author "Forster, Martin" Remove constraint Author: "Forster, Martin" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
326 results on '"Forster, Martin"'

Search Results

1. CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer

2. Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trial

4. Eftilagimod Alpha (a Soluble LAG-3 Protein) Combined With Pembrolizumab in Second-Line Metastatic NSCLC Refractory to Anti–Programmed Cell Death Protein 1/Programmed Death-Ligand 1-Based Therapy: Final Results from a Phase 2 Study

6. Psychometric Properties of the Parental Stress Scale in Swedish Parents of Children with and without Neurodevelopmental Conditions

8. Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation

12. The evolution of non-small cell lung cancer metastases in TRACERx

13. The evolution of lung cancer and impact of subclonal selection in TRACERx

17. EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study

18. Use of heart failure medical therapy before and after a cancer diagnosis: A longitudinal study.

19. The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer.

22. DNA methylation-based classification of sinonasal tumors

23. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

26. Five Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death-Ligand 1–Positive Advanced NSCLC

28. CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer

29. Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

31. Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours

32. The National Lung Matrix Trial of personalized therapy in lung cancer

33. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy

36. Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial

37. The performance of a Bayesian value-based sequential clinical trial design in the presence of an equivocal cost-effectiveness signal: evidence from the HERO trial.

38. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

39. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

44. Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

45. The SAVRY Improves Prediction of Reoffending: A Naturalistic Longitudinal Comparative Study

47. Targeting DNA damage in SCLC

48. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

Catalog

Books, media, physical & digital resources